145 related articles for article (PubMed ID: 32594423)
1. Tumor lysis syndrome in a patient with metastatic melanoma treated with nivolumab.
Sugimoto S; Terashima T; Yamashita T; Iida N; Kitahara M; Hodo Y; Shimakami T; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Shirota Y; Sato K; Mizukoshi E; Honda M; Harada K; Kaneko S
Clin J Gastroenterol; 2020 Oct; 13(5):935-939. PubMed ID: 32594423
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F
Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088
[TBL] [Abstract][Full Text] [Related]
3. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
4. Tumor lysis syndrome and metastatic melanoma.
Meeks MW; Hammami MB; Robbins KJ; Cheng KL; Lionberger JM
Med Oncol; 2016 Dec; 33(12):134. PubMed ID: 27807723
[TBL] [Abstract][Full Text] [Related]
5. Tumor lysis syndrome associated with nivolumab plus ipilimumab combination therapy in a melanoma patient.
Magara A; Kato H; Oda T; Nakamura M; Komatsu H; Morita A
J Dermatol; 2020 Nov; 47(11):e411-e412. PubMed ID: 32856327
[No Abstract] [Full Text] [Related]
6. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report.
Okamoto T; Nakano E; Yamauchi T
J Med Case Rep; 2021 Jul; 15(1):345. PubMed ID: 34256852
[TBL] [Abstract][Full Text] [Related]
7. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
Ozaki Y; Shindoh J; Miura Y; Nakajima H; Oki R; Uchiyama M; Masuda J; Kinowaki K; Kondoh C; Tanabe Y; Tanaka T; Haruta S; Ueno M; Kitano S; Fujii T; Udagawa H; Takano T
BMC Cancer; 2017 Nov; 17(1):778. PubMed ID: 29162045
[TBL] [Abstract][Full Text] [Related]
8. Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case report.
Shimizu Y; Sunagozaka H; Yamagata K; Hirai H; Miura M; Yonemoto Y; Naito Y; Hasatani K; Yoshikawa J; Aoyagi H; Kaneko S
Clin J Gastroenterol; 2021 Apr; 14(2):645-649. PubMed ID: 33389590
[TBL] [Abstract][Full Text] [Related]
9. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.
Drakos P; Bar-Ziv J; Catane R
Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169
[TBL] [Abstract][Full Text] [Related]
10. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
11. Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.
McDonald MA; Sanghvi P; Bykowski J; Daniels GA
BMC Cancer; 2018 May; 18(1):549. PubMed ID: 29743050
[TBL] [Abstract][Full Text] [Related]
12. From skin to spontaneous lysis: A case of spontaneous tumor lysis syndrome in metastatic melanoma.
Durham CG; Herrington J; Seago S; Williams C; Holguin MH
J Oncol Pharm Pract; 2018 Apr; 24(3):221-225. PubMed ID: 29284345
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
Gambichler T; Strutzmann S; Tannapfel A; Susok L
BMC Cancer; 2017 May; 17(1):327. PubMed ID: 28499411
[TBL] [Abstract][Full Text] [Related]
14. Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
Pillonel V; Dunet V; Hottinger AF; Berthod G; Schiappacasse L; Peters S; Michielin O; Aedo-Lopez V
J Immunother Cancer; 2019 Dec; 7(1):336. PubMed ID: 31791418
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy.
Colak R; Kapar C; Gulturk I; Yilmaz M
J Oncol Pharm Pract; 2024 Apr; 30(3):589-593. PubMed ID: 38111303
[TBL] [Abstract][Full Text] [Related]
16. Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literature.
Habib GS; Saliba WR
Am J Med Sci; 2002 Mar; 323(3):155-7. PubMed ID: 11908861
[TBL] [Abstract][Full Text] [Related]
17. A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome.
Joshita S; Yoshizawa K; Sano K; Kobayashi S; Sekiguchi T; Morita S; Kamijo A; Komatsu M; Umemura T; Ichijo T; Matsumoto A; Tanaka E
Intern Med; 2010; 49(11):991-4. PubMed ID: 20519814
[TBL] [Abstract][Full Text] [Related]
18. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.
Takahashi A; Kubo A; Mizuno S; Kasai K; Asai N; Yonezawa T; Kosaka K; Nishimura M; Tanaka H; Yokoe N; Tsuzuki T; Takami A; Yamaguchi E
Intern Med; 2019 Mar; 58(6):827-831. PubMed ID: 30449777
[TBL] [Abstract][Full Text] [Related]
19. Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma.
Gao CA; Weber UM; Peixoto AJ; Weiss SA
J Immunother Cancer; 2019 Oct; 7(1):262. PubMed ID: 31623673
[TBL] [Abstract][Full Text] [Related]
20. Association of Tumor Lysis Syndrome and Metastatic Melanoma.
Kelkar N; Wang J
Cureus; 2021 Sep; 13(9):e18108. PubMed ID: 34692319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
